Literature DB >> 12673781

Polyol pathway and protein kinase C activity of rat Schwannoma cells.

Hideki Kamiya1, Jiro Nakamura, Yoji Hamada, Eitaro Nakashima, Keiko Naruse, Koichi Kato, Yutaka Yasuda, Nigishi Hotta.   

Abstract

BACKGROUND: Polyol pathway hyperactivity-induced decreases in protein kinase C (PKC) activities have been proposed as a pathogenic mechanism of diabetic neuropathy. Increased PKC activities have recently been invoked in the pathogenesis of other diabetic complications, especially retinopathy, nephropathy, and macroangiopathy. However, it remains unclear whether PKC activities in neural cells such as Schwann cells are increased, decreased, or unchanged. This study investigated the effects of high glucose and increased polyol pathway activity on neural cell growth and PKC activities.
METHODS: Rat Schwannoma cells were cultured in 5.5 or 20 mM glucose in the presence or absence of an aldose reductase inhibitor, epalrestat (1 microM) for 14 days. Proliferation activities, PKC activities, and the protein expression of PKC isoforms were measured.
RESULTS: Proliferation and PKC activities under the 20 mM glucose condition were significantly decreased compared to those under the 5.5 mM glucose condition and were prevented by epalrestat. Among PKC isoforms, the protein expression of PKC-alpha under the 20 mM glucose condition was significantly reduced compared to that under the 5.5 mM glucose condition. Epalrestat significantly inhibited the decreased expression of PKC-alpha protein. There were no significant changes in the protein expression of PKC-beta.
CONCLUSIONS: These results suggest that PKC, especially PKC-alpha activity, is decreased in Schwann cells exposed to high glucose and that this deficit is mediated through polyol pathway hyperactivity. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12673781     DOI: 10.1002/dmrr.354

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  10 in total

1.  Restoration of ultrastructural and biochemical changes in alloxan-induced diabetic rat sciatic nerve on treatment with Na3VO4 and Trigonella--a promising antidiabetic agent.

Authors:  Anju Preet; Bihari L Gupta; Mohamed R Siddiqui; Pramod K Yadava; Nazma Zaheer Baquer
Journal:  Mol Cell Biochem       Date:  2005-10       Impact factor: 3.396

Review 2.  Targeting aldose reductase for the treatment of cancer.

Authors:  Ravinder Tammali; Satish K Srivastava; Kota V Ramana
Journal:  Curr Cancer Drug Targets       Date:  2011-06       Impact factor: 3.428

3.  A brief review of in vitro models of diabetic neuropathy.

Authors:  Namita G Hattangady; Medha S Rajadhyaksha
Journal:  Int J Diabetes Dev Ctries       Date:  2009-10

4.  Effect of Jinmaitong serum on the proliferation of rat Schwann cells cultured in high glucose medium.

Authors:  Ling QU; Xiao-chun LIANG; Hong ZHANG; Qun-li WU; Lian-qing SUN; Bei GU
Journal:  Chin J Integr Med       Date:  2008-12-12       Impact factor: 1.978

Review 5.  Mechanism of diabetic neuropathy: Where are we now and where to go?

Authors:  Soroku Yagihashi; Hiroki Mizukami; Kazuhiro Sugimoto
Journal:  J Diabetes Investig       Date:  2011-01-24       Impact factor: 4.232

6.  High Glucose-Induced PC12 Cell Death by Increasing Glutamate Production and Decreasing Methyl Group Metabolism.

Authors:  Minjiang Chen; Hong Zheng; Tingting Wei; Dan Wang; Huanhuan Xia; Liangcai Zhao; Jiansong Ji; Hongchang Gao
Journal:  Biomed Res Int       Date:  2016-06-19       Impact factor: 3.411

7.  Insulin enhances neurite extension and myelination of diabetic neuropathy neurons.

Authors:  Vuong M Pham; Nitish Thakor
Journal:  Korean J Pain       Date:  2022-04-01

Review 8.  Pathogenesis of Distal Symmetrical Polyneuropathy in Diabetes.

Authors:  Sasha Smith; Pasha Normahani; Tristan Lane; David Hohenschurz-Schmidt; Nick Oliver; Alun Huw Davies
Journal:  Life (Basel)       Date:  2022-07-19

9.  Status and Trends of the Association Between Diabetic Nephropathy and Diabetic Retinopathy From 2000 to 2021: Bibliometric and Visual Analysis.

Authors:  Wenwen Lin; Yayong Luo; Fang Liu; Hangtian Li; Qian Wang; Zheyi Dong; Xiangmei Chen
Journal:  Front Pharmacol       Date:  2022-06-20       Impact factor: 5.988

Review 10.  Antiangiogenic cytokines as potential new therapeutic targets for resveratrol in diabetic retinopathy.

Authors:  Mihaela Popescu; Cătălina Bogdan; Adela Pintea; Dumitriţa Rugină; Corina Ionescu
Journal:  Drug Des Devel Ther       Date:  2018-07-03       Impact factor: 4.162

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.